Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Stelara
Stelara
Celgene Vs. Rivals In Psoriatic Arthritis Drug Race
Seeking Alpha
Wed, 11/20/13 - 08:29 am
psoriatic arthritis
Celgene
AbbVie
Amgen
JNJ
Merck
Humira
apremilast
Enbrel
Stelara
Simponi
Remicade
Johnson & Johnson Continues To Ride The Success Of Its Immunology And Oncology Drugs
Seeking Alpha
Fri, 10/18/13 - 10:07 am
JNJ
Remicade
Simponi
Stelara
Invokana
Express Scripts stops covering key Big Pharma drugs on cost-effectiveness grounds
Fierce Pharma
Thu, 10/10/13 - 10:01 am
Express Scripts
Pfizer
Xeljanz
PBMs
JNJ
Stelara
GSK
Breo Ellipta
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
J&J says Stelara approved for psoriatic arthritis
Yahoo/AP
Mon, 09/23/13 - 10:57 am
Stelara
JNJ
psoriatic arthritis
Johnson & Johnson Receives Boost in This Key Market
Motley Fool
Sat, 08/3/13 - 10:24 am
Stelara
psoriatic arthritis
JNJ
J&J's Stelara effective in psoriatic arthritis trial
Reuters
Tue, 06/11/13 - 10:45 pm
JNJ
Stelara
psoriatic arthritis
3 Things You Need to Watch at Johnson & Johnson
Motley Fool
Wed, 04/17/13 - 04:38 pm
JNJ
devices
Invokana
Stelara
Is Celgene's Apremilast A Potential Blockbuster Or Not?
Seeking Alpha
Fri, 04/12/13 - 09:48 am
Celgene
apremilast
AbbVie
Amgen
JNJ
Humira
Stelara
psoriasis
Enbrel
Can New Psoriasis Drugs Scratch Investors' Itch?
Investors.com
Thu, 04/4/13 - 01:52 pm
investors
psoriasis
Amgen
Eli Lilly
Pfizer
Novartis
Celgene
Humira
AbbVie
Stelara
Remicade
Enbrel
apremilast
brodalumab
Xeljanz
Can JAK Inhibitors Challenge Biologics?
Motley Fool
Wed, 02/20/13 - 05:15 pm
JAK inhibitors
Remicade
JNJ
Enbrel
Stelara
Amgen
Humira
AbbVie
Can Johnson & Johnson Cash In on Stelara?
Motley Fool
Mon, 02/11/13 - 08:23 am
Stelara
JNJ
anti-inflammatories
Can Johnson & Johnson Cash In on Stelara?
Motley Fool
Sat, 02/9/13 - 12:06 pm
JNJ
Stelara
psoriasis
rheumatoid arthritis
Chron's Disease
Johnson & Johnson files for approval to market Stelara for psoriatic arthritis in US and EU
Yahoo/AP
Thu, 12/6/12 - 11:51 am
psoriatic arthritis
JNJ
Stelara
Crohn's patients respond to J&J's Stelara in study
Reuters
Mon, 05/9/11 - 09:22 am
JNJ
Stelara
Crohn's Disease
J&J Has Success with Psoriasis Treatment
Seeking Alpha
Tue, 01/19/10 - 09:25 am
psoriasis
JNJ
Amgen
Abbott Laboratories
Enbrel
Humira
Stelara
Why J&J's Stelara Launch Should Target Dermatologists First
BNET Pharma
Sun, 11/22/09 - 03:53 pm
JNJ
Stelara
dermatologists
psoriasis
J&J's Knockout Drug
Motley Fool
Mon, 09/28/09 - 03:54 pm
JNJ
Stelara
Amgen
Wyeth
psoriasis
Humira
Embrel
J&J unit gets FDA approval for psoriasis drug
Yahoo/AP
Sat, 09/26/09 - 11:03 am
JNJ
Stelara
Janssen Biotech
J&J unit gets FDA approval for psoriasis drug
Yahoo/AP
Sat, 09/26/09 - 11:04 am
JNJ
Stelara
Janssen Biotech
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »